Pre-clinical assessment of poly-arginine peptide R18D as a therapeutic to reduce central nervous system injury following neurotrauma

Project Details

StatusFinished
Effective start/end date1/07/1730/06/18

Funding

  • Neurotrauma Research Program (NRP): AUD49,415.00
  • Neurotrauma Research Program (NRP): AUD50,235.00